Cota Capital reposted this
#ICYMI In our latest webinar, Adam Sciambi, PhD, CTO at Mission Bio, discussed how single-cell analysis can be leveraged to identify SMM clones that drive Myeloma progression and therapy resistance. In this webinar, he: 🔬 Provides an overview of Multiple Myeloma (MM) and why there's a need for clonal analysis 🔬 Gives a preview of the Tapestri Single-cell Multiple Myeloma Multiomics Solution that uncovers complex clonal heterogeneity underlying myeloma evolution and biology 🔬 Shares novel data identifying the clonal populations that progress to active MM or resistant disease Watch anytime on-demand 👉 https://lnkd.in/gsk2kuub #multiplemyeloma #myeloma #therapyresistance #singlecell #multiomics
